Pharma giants pressed by Senate Democrats over Trump pricing deals
2026-03-06 10:45:02 ET
More on Pfizer, Merck, etc.
- Pfizer: Obesity Hype And Vaccine Policy Shocks
- AbbVie: Stabilizes Near $233 While Testing Resistance
- Pfizer's Portfolio Renewal In Progress - High Yields For The Patient
- China approves Pfizer’s GLP-1 drug for weight management, intensifying market competition
- J&J wins FDA nod for multiple myeloma therapy
Read the full article on Seeking Alpha
For further details see:
Pharma giants pressed by Senate Democrats over Trump pricing dealsNASDAQ: NVS
NVS Trading
-0.41% G/L:
$159.175 Last:
2,310,454 Volume:
$156.71 Open:



